Express

Prenetics Sells Ownership of ACT Genomics for $71.78 Million, Plans to Strengthen Bitcoin Financial Strategy

Summary: According to reports, NASDAQ-listed company Prenetics has announced a final agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately $71.78 million. The divestment of ACT Genomics significantly enhances Prenetics' financial foundation, with an estimated cash reserve of around $86 million and cash and short-term assets totaling ...

According to reports, NASDAQ-listed company Prenetics has announced a final agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately $71.78 million. The divestment of ACT Genomics significantly enhances Prenetics' financial foundation, with an estimated cash reserve of around $86 million and cash and short-term assets totaling $117 million. The company maintains a debt-free balance sheet, allowing for exploration of other financial management solutions, including adoption of digital assets and a Bitcoin financial strategy.

Last Update:

Tags:
Link: Prenetics Sells Ownership of ACT Genomics for $71.78 Million, Plans to Strengthen Bitcoin Financial Strategy   [Copy]
  • AI Fraud Is Breaking the Internet’s Trust Economy. Can Compliance Tech Keep Up? 2 days ago
  • Can a $300M RWA Fund Save Avalanche's TVL? 3 days ago
  • Trump Adviser's "Whale Debut" with $680M Bitcoin Bet Faces Early Losses 4 days ago
  • S&P 500 Enters Key Turning Point Window; A Cautious "Wait-and-See" Approach is Adv... 6 days ago
  • Why a "One-Size-Fits-All" Approach to Stablecoin Issuance Fails Given Diverse Fiat Curr... 7 days ago
  • You need to login to comment.